Effect of PCSK9 inhibitor on lipoprotein particles in patients with acute coronary syndromes

Overview of attention for article published in BMC Cardiovascular Disorders, January 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 34 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 12 publications that cite this research output.

12

The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.

Efficacy and Safety of PSCK9 Inhibitors on Patients with Acute Coronary Syndrome: A Systematic Review and Meta-Analysis of Randomised Controlled Trials

Article in Reviews in Cardiovascular Medicine (March 2024)

Mesenchymal stem cell‐derived extracellular vesicles for metabolic syndrome therapy: Assessing efficacy with nuclear magnetic resonance spectroscopy

Article in Cell Biochemistry and Function (November 2023)

Effect of PCSK9 inhibition on plasma levels of small dense low density lipoprotein-cholesterol and 7-ketocholesterol

Article in Journal of Clinical Lipidology (October 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.